The overall message is consistent across compartments—YTHDF1 acts as a brake on T-cell entry and activation—even though the dominant downstream pathway (lysosomal antigen/MHC-I turnover in tumor cells versus STING erosion in DCs) differs by cell type and stimulus (53, 88). Here, YTHDF1 is linked to neoplasm.